Clinical investigation of plasma-derived antithrombin products - Scientific guideline

HumanScientific guidelines

Slovenian is available via eTranslation, the European Commission's machine translation service.

Translate to Slovenian | Important information about machine translation

This document summarises the clinical trials required for authorisation of new and modified human plasma derived antithrombin products.

Keywords: Congenital antithombin deficiency, acquired antithombin deficiency

Current effective version

Share this page